Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components (Details) - Schedule of accrued liabilities

v3.23.1
Balance Sheet Components (Details) - Schedule of accrued liabilities - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Accrued Liabilities [Abstract]    
Accrued labor costs $ 1,487 $ 691
Accrued drug development costs 228 369
Other 522 152
Total $ 2,237 $ 1,212